Eli Lilly | LLY - Interest Expense On Debt

Stock Price
1,002.14
Daily Change
-41.99 -4.02%
Monthly
-3.78%
Yearly
21.31%
Q1 Forecast
1,005.21

Eli Lilly reported $114.7M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Abbott USD 42M 2M Dec/2025
ALKERMES USD 4.65M 1.35M Dec/2024
Amgen USD 685M 9M Sep/2025
AstraZeneca USD 303M 38M Jun/2025
Baxter International USD 58M 14M Sep/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 480M 5M Sep/2025
Drreddys Laboratories INR 944M 127M Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Gilead Sciences USD 254M 6M Jun/2025
GlaxoSmithKline GBP 167M 17M Sep/2025
Glaxosmithkline GBP 177.95M 6.05M Sep/2025
J&J USD 18M 290M Sep/2025
Medtronic USD 181M 5M Sep/2025
Merck USD 327M 22M Sep/2025
Neurocrine Biosciences USD 1.1M 0 Mar/2024
Novartis USD 281M 8M Sep/2025
Novartis USD 281M 8M Sep/2025
Novo Nordisk DKK 1.53B 3.43B Sep/2025
Perrigo USD 10.08B 10.04B Sep/2025
Pfizer USD 652M 2M Sep/2025
Prestige Brands USD 10.04M 167K Sep/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025
Sanofi EUR -25M 99.78M Dec/2025
United Therapeutics USD 3M 4.3M Sep/2025
Zoetis USD 58M 5M Sep/2025